US Stock MarketDetailed Quotes

CLDWW CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM)

Watchlist
  • 0.014
  • 0.0000.00%
15min DelayClose Dec 9 16:00 ET
0Market Cap0.00P/E (TTM)

CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM) Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
-89.98%45K
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
-89.98%45K
--0
Cost of revenue
0
-85.11%14K
0
Gross profit
0
-91.27%31K
0
Operating expense
-19.94%5.23M
-1.01%5.59M
42.96%6.75M
12.73%26.11M
96.42%9.21M
-6.56%6.53M
5.65M
4.72M
113.70%23.16M
41.20%4.69M
Selling and administrative expenses
-22.59%3.07M
7.29%3.61M
43.59%4.01M
0.52%15.98M
141.73%5.86M
-21.25%3.97M
--3.36M
--2.79M
158.02%15.9M
24.68%2.43M
-General and administrative expense
-22.59%3.07M
7.29%3.61M
43.59%4.01M
0.52%15.98M
141.73%5.86M
-21.25%3.97M
--3.36M
--2.79M
158.02%15.9M
24.68%2.43M
Research and development costs
-33.77%2.15M
-31.79%2.17M
4.61%2.74M
79.25%13.01M
74.90%3.96M
67.15%3.25M
--3.18M
--2.62M
55.26%7.26M
64.58%2.26M
Other operating expenses
----
79.64%-181K
----
---2.89M
---612K
---693K
---889K
---691K
----
----
Operating profit
19.94%-5.23M
1.01%-5.59M
-42.96%-6.75M
-12.88%-26.11M
-96.42%-9.21M
6.56%-6.53M
-5.65M
-4.72M
-120.64%-23.13M
-58.11%-4.69M
Net non-operating interest income expense
28.40%-232K
90.86%-273K
-16.59%-253K
-2,272.78%-3.75M
-126.53%-222K
-1,017.24%-324K
-2.99M
-217K
74.27%-158K
-58.06%-98K
Non-operating interest expense
-28.40%232K
-10.78%273K
16.59%253K
576.58%1.07M
126.53%222K
1,017.24%324K
--306K
--217K
-74.27%158K
58.06%98K
Total other finance cost
----
----
----
--2.68M
--0
----
--2.68M
----
----
----
Other net income (expense)
-91.98%388K
102.72%105K
85.77%-216K
130.80%656K
140.30%1.2M
191.33%4.84M
-3.86M
-1.52M
-1,324.14%-2.13M
-547.71%-2.97M
Gain on sale of security
-92.85%380K
102.47%95K
86.85%-199K
155.44%1.18M
141.22%1.22M
220.94%5.32M
---3.85M
---1.51M
-1,032.02%-2.13M
-257.92%-2.96M
Special income (charges)
--0
----
----
---471K
--0
---471K
----
----
--0
--0
-Less:Other special charges
----
----
----
--471K
--0
--471K
----
----
----
----
Other non- operating income (expenses)
200.00%8K
162.50%10K
-240.00%-17K
-920.00%-51K
-69.23%-22K
-300.00%-8K
---16K
---5K
-155.56%-5K
-316.67%-13K
Income before tax
-151.86%-5.07M
53.92%-5.76M
-11.81%-7.22M
-14.89%-29.2M
-6.10%-8.23M
62.40%-2.01M
-12.5M
-6.46M
-132.70%-25.42M
-122.58%-7.76M
Income tax
-109.09%-1K
100.00%8K
0.00%4K
45.45%16K
0.00%-3K
1,000.00%11K
4K
4K
0.00%11K
-200.00%-3K
Net income
-150.44%-5.07M
53.87%-5.77M
-11.81%-7.23M
-14.90%-29.22M
-6.10%-8.23M
62.20%-2.02M
-12.5M
-6.46M
-132.57%-25.43M
-122.30%-7.76M
Net income continuous Operations
-150.44%-5.07M
53.87%-5.77M
-11.81%-7.23M
-14.90%-29.22M
-6.10%-8.23M
62.20%-2.02M
---12.5M
---6.46M
-132.57%-25.43M
-122.30%-7.76M
Minority interest income
-15K
0
Net income attributable to the parent company
-149.70%-5.05M
53.87%-5.77M
-11.81%-7.23M
-14.90%-29.22M
-6.10%-8.23M
62.20%-2.02M
-12.5M
-6.46M
-132.57%-25.43M
-122.30%-7.76M
Preferred stock dividends
Other preferred stock dividends
0
1.67M
0
0
Net income attributable to common stockholders
-149.70%-5.05M
40.50%-7.44M
-11.81%-7.23M
-14.90%-29.22M
-6.10%-8.23M
62.20%-2.02M
-12.5M
-6.46M
-132.57%-25.43M
-122.30%-7.76M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 00000000-89.98%45K0
Operating revenue --0--0--0--0--0--0--0--0-89.98%45K--0
Cost of revenue 0-85.11%14K0
Gross profit 0-91.27%31K0
Operating expense -19.94%5.23M-1.01%5.59M42.96%6.75M12.73%26.11M96.42%9.21M-6.56%6.53M5.65M4.72M113.70%23.16M41.20%4.69M
Selling and administrative expenses -22.59%3.07M7.29%3.61M43.59%4.01M0.52%15.98M141.73%5.86M-21.25%3.97M--3.36M--2.79M158.02%15.9M24.68%2.43M
-General and administrative expense -22.59%3.07M7.29%3.61M43.59%4.01M0.52%15.98M141.73%5.86M-21.25%3.97M--3.36M--2.79M158.02%15.9M24.68%2.43M
Research and development costs -33.77%2.15M-31.79%2.17M4.61%2.74M79.25%13.01M74.90%3.96M67.15%3.25M--3.18M--2.62M55.26%7.26M64.58%2.26M
Other operating expenses ----79.64%-181K-------2.89M---612K---693K---889K---691K--------
Operating profit 19.94%-5.23M1.01%-5.59M-42.96%-6.75M-12.88%-26.11M-96.42%-9.21M6.56%-6.53M-5.65M-4.72M-120.64%-23.13M-58.11%-4.69M
Net non-operating interest income expense 28.40%-232K90.86%-273K-16.59%-253K-2,272.78%-3.75M-126.53%-222K-1,017.24%-324K-2.99M-217K74.27%-158K-58.06%-98K
Non-operating interest expense -28.40%232K-10.78%273K16.59%253K576.58%1.07M126.53%222K1,017.24%324K--306K--217K-74.27%158K58.06%98K
Total other finance cost --------------2.68M--0------2.68M------------
Other net income (expense) -91.98%388K102.72%105K85.77%-216K130.80%656K140.30%1.2M191.33%4.84M-3.86M-1.52M-1,324.14%-2.13M-547.71%-2.97M
Gain on sale of security -92.85%380K102.47%95K86.85%-199K155.44%1.18M141.22%1.22M220.94%5.32M---3.85M---1.51M-1,032.02%-2.13M-257.92%-2.96M
Special income (charges) --0-----------471K--0---471K----------0--0
-Less:Other special charges --------------471K--0--471K----------------
Other non- operating income (expenses) 200.00%8K162.50%10K-240.00%-17K-920.00%-51K-69.23%-22K-300.00%-8K---16K---5K-155.56%-5K-316.67%-13K
Income before tax -151.86%-5.07M53.92%-5.76M-11.81%-7.22M-14.89%-29.2M-6.10%-8.23M62.40%-2.01M-12.5M-6.46M-132.70%-25.42M-122.58%-7.76M
Income tax -109.09%-1K100.00%8K0.00%4K45.45%16K0.00%-3K1,000.00%11K4K4K0.00%11K-200.00%-3K
Net income -150.44%-5.07M53.87%-5.77M-11.81%-7.23M-14.90%-29.22M-6.10%-8.23M62.20%-2.02M-12.5M-6.46M-132.57%-25.43M-122.30%-7.76M
Net income continuous Operations -150.44%-5.07M53.87%-5.77M-11.81%-7.23M-14.90%-29.22M-6.10%-8.23M62.20%-2.02M---12.5M---6.46M-132.57%-25.43M-122.30%-7.76M
Minority interest income -15K0
Net income attributable to the parent company -149.70%-5.05M53.87%-5.77M-11.81%-7.23M-14.90%-29.22M-6.10%-8.23M62.20%-2.02M-12.5M-6.46M-132.57%-25.43M-122.30%-7.76M
Preferred stock dividends
Other preferred stock dividends 01.67M00
Net income attributable to common stockholders -149.70%-5.05M40.50%-7.44M-11.81%-7.23M-14.90%-29.22M-6.10%-8.23M62.20%-2.02M-12.5M-6.46M-132.57%-25.43M-122.30%-7.76M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.